Until law, GLP-1 drugs were used to treat diabetes, obesity and even the recent evidences suggest that it could as well be used to treat chronic kidney problems. There is yet another research, published in JAMA Psychiatry on February 25, titled Once-Weekly Semaglutide in Adults With Alcohol Use Disorder: A Randomized Clinical Trial that explores if GLP-1 receptor agonist semaglutide reduce alcohol consumption and cravings in adults with alcohol use disorder.

What Do Studies Say?

The research was conducted over a period of 9 weeks, where in the randomized clinical trial, the participants who were administered semaglutide, it led to reductions in some but not all measures of weekly consumptions. It also reduced weekly alcohol and craving related to placebo, and also led to a greater relative reduction in cigarettes per day.

The research also found that weekly injections of semaglutide, which is the active ingredient in weight loss drugs like Wegovy also helped reduce cravings in people with alcohol use disorder.

The lead author Christian Hendershot said that these findings will help in developing new approaches to treat alcoholism. "Two drugs currently approved to reduce alcohol consumption aren't widely used. The popularity of Ozempic and other GLP-1 receptor agonists increases the chances of broad adoption of these treatments for alcohol use disorder," said Hendershot in news release by the University of Southern California's Institute for Addiction Research, where he is the director.

The study is government-funded research and was funded by the National Institute on Alcohol Abuse and Alcoholism, part of the National Institutes of Health.

How Was The Study Conducted?

The study was small, and took in account for only 48 adults over two months, thus experts say that it is not yet clear how safe these drugs are for people who do not need to lose weight. Though the results do add up with the evidence form animal studies on drugs like Ozempic and Wegovy on how it helps manage cravings, not just for food, but also for tobacco and alcohol. Scientists are also studying these drugs on smokers, people with opioid addiction and cocaine users.

Co-author Dr Klara Klein of the University of North Carolina at Chapel Hill who treats people with obesity and diabetes said, "This is such promising data. And we need more of it. We frequently will hear that once people start these medications that their desire to drink is very reduced, if not completely abolished."

Why Does It Work So Well Against Alcoholism?

The GLP-1 receptor agonists work by mimicking hormones GLP-1 in the gut and brain that regulates appetite and feelings of fullness. This response is what helps one lose weight, and what helps one curb their craving for alcohol. These drugs that mimic the functioning of your brain, which is responsible to tell your body when to stop consuming, are the same hormones that tell your body about other kinds of consumptions, including alcohol. Therefore by consuming the weight loss drugs one can treat alcohol use disorder.

However, the researchers have pointed out on the limited data on the research and have suggested to continue using the three approved drugs by the National Institute on Alcohol Abuse and Alcoholism and Substance Abuse and Mental Health Services Administration, namely, Disulfiram, Naltrexone, and Acamprosate to treat alcohol use disorder until large studies confirm these findings.

A 2026 target trial emulation has found that glucagon-like peptide, also known as GLP-1, which is used by type-2 diabetes patients, can raise the risk of suffering from erectile dysfunction. According to a report published in the European Medical Journal, the impact of GLP-1s on sexual health outcomes in diabetic men has been inconsistent and limited. Erectile dysfunction, however, has been a prominent complication affecting 50 per cent of men with type-2 diabetes over their lifetime.

The effect of GLP-1 on men with type-2 diabetes

For this, researchers analysed the electronic health records of men aged 18 years and above with type-2 diabetes in the US from January 2019 to September 2024. Participants were started on treatment with either dipeptidyl peptidase-4 inhibitors (DPP4i) or GLP-1, with 5,524 and 4,910 individuals, respectively. Men with a history of erectile dysfunction diagnosis or end-stage renal disease were not part of the study population. The mean age of these men was 63 years, and the average BMI was 32.8—55 per cent of participants were White, and 23 per cent were Black. GLP-1 users were younger and had a higher prevalence of obesity compared to DPP4i users.

Higher rate of erectile dysfunction

Experts involved in the study found that the incidence of erectile dysfunction in the GLP-1 group was about 35 cases per 1,000 person-years. In the case of DPP4i users, the number dropped to 28 per 1,000 person-years. Hence, people in the GLP-1 cohort had a 26 per cent higher risk of developing erectile dysfunction over a three-year follow-up period. Results were consistent across subgroups; however, they lacked statistical significance after adjustment for negative outcomes.

Can GLP-1 cause erectile dysfunction?

Researchers noted that the findings of the target trial emulation suggest that sexual health outcomes must be considered in diabetic men, especially those dealing with type-2 diabetes and undergoing treatment with GLP-1 drugs. These findings also highlight the need for randomised trials with standardised erectile dysfunction assessments to further investigate biological pathways.

What complications does type-2 diabetes cause in men?

Type-2 diabetes can cause the following complications in men:

1. Heart disease
2. Stroke
3. Erectile dysfunction
4. Kidney disease
5. Retrograde ejaculation
6. Lower testosterone levels
7. Urinary retention or frequent urination
8. Vision loss—diabetic retinopathy

New global guidelines have just been released for breast cancer screening, and they involve the introduction of artificial intelligence in the process. Breast cancer is one of the most commonly diagnosed forms of tumour in women globally. In India, it is the most common form of cancer detected in women living in metro cities. According to the National Comprehensive Cancer Network (NCCN), a non-profit alliance of 33 cancer treatment centres in the US, women aged 35 years and above should be eligible for AI-powered mammogram risk assessment rather than at a later stage.

Why is timely prediction of cancer risk important?

The NCCN aims to boost the diagnosis rates of breast cancer by paving the way for accurate predictions of risks. This will, over time, help achieve timely screening. As per experts, this change in global breast cancer screening guidelines, especially the integration of AI in the process, marks a paradigm shift—from a detection-first to a prediction-first approach. Historically, mammograms were used after the age of 40 for the detection of existing cancers. The modern guidelines, however, recommend that women get screened from the age of 35 onwards, with AI algorithms used to predict future risks.

What this means for India

Experts say that this shift is important for India. In India, breast cancer is the most prevalent form of tumour among women, and delayed diagnosis is one of the reasons responsible for the current mortality rate. Breast cancer is also often diagnosed late because of the unavailability and limited accessibility of screening facilities. Introducing AI in this process can help bridge the gap in several ways.

Doctors say that the introduction of AI in the breast cancer screening process will help facilitate the identification of high-risk patients, regardless of their family history or the presence of genetic markers. This is important because most cases of breast cancer do not arise from these factors. This helps provide screening in a way that does not require universal testing.

Traditional screening methods for breast cancer

Traditionally, cancer screening largely depends on family history and age. AI, however, can now analyse large volumes of imaging data, clinical history, breast density, and genetic factors for a more personalised approach and targeted diagnostic methods. The adoption of AI-driven risk assessment can help improve patient outcomes, as per doctors.

Use of AI in breast cancer detection

Women at high risk of breast cancer can make detection easier for themselves by making use of advanced modalities such as MRI. An MIT-developed AI-based breast cancer risk model can detect tumours up to five years in advance using mammographic data alone. This AI-based risk assessment technique has also been recommended by global experts and is published in The Lancet. The study found consistent favourable outcomes.

Rising global temperatures are driving heatwave conditions in India, said the Indian government, while releasing an advisory to warn people about the increased health risks.

Taking to the social media platform X, the Ministry of Health and Family Welfare urged the public to take precautions during extreme heat.

"Heat waves are increasing due to rising global temperatures," said the Ministry in the advisory.

It shared safety measures and an informative poster explaining the impact of rising temperatures and steps to manage heat stroke.

The poster highlighted that a rise of 1 degree Celsius in global temperatures can lead to longer durations of heatwaves.

Further, it stated that insufficient hydration during heatwaves reduces the body's natural ability to cool itself, which can result in heat stroke.

The poster also detailed preventive measures to avoid heat stroke. It also advised people to avoid heavy work during mid-noon hours, drink plenty of water, avoid consuming heavily caffeinated or sugary drinks as they may cause dehydration, wear light-colored clothes, and take frequent breaks while working outdoors.

Which States Are At Risk?

The India Meteorological Department (IMD) has warned of heatwave conditions in several parts of the country.

Regions likely to face extreme heatwave conditions until April 20 include Telangana and Rayalaseema, Madhya Maharashtra and Marathwada, North Interior Karnataka, Madhya Pradesh, Chhattisgarh, Vidarbha, Odisha, Jharkhand, and West Rajasthan.

In addition, hot and humid weather conditions are expected in coastal regions such as Kerala, Tamil Nadu, Gujarat, and Coastal Andhra Pradesh.

Meanwhile, the national capital saw its hottest day of the year on Wednesday, as temperatures climbed sharply, signaling the onset of harsher summer conditions. According to IMD, the maximum temperature at Safdarjung, the city’s base station, touched 39.2 degrees Celsius, about 3 degrees above normal. This surpassed Tuesday’s 38.2 degrees Celsius, marking a noticeable upward trend.

While the mercury is expected to inch closer to 42 degrees Celsius by Friday, the weather office has ruled out heatwave conditions for at least the next week.

“A gradual rise is expected in maximum temperatures by 2-3 degrees during the next three days and fall by 1-2 degrees thereafter. The maximum temperatures are likely to be above normal to appreciably above normal during the next seven days," Times Of India quoted a Met official as saying.

As per the weather department, despite a slight chance of light rain in parts of Haryana and NCR on April 17 and 18, there is no relief expected for Delhi.

Forecasts suggest daytime temperatures will hover between 39 degrees Celsius and 41 degrees Celsius on Thursday, rising further to 40-42 degrees Celsius from Friday through Sunday.

The IMD has cautioned that such above-normal temperatures could pose moderate health risks, especially for infants, elderly individuals, and those with chronic illnesses.

Hydration Is key, Say Doctors

Dr. Anil Gomber, Director and Senior Consultant – Internal Medicine & Diabetologist, Yatharth Hospital, told HealthandMe: “It is crucial to take preventive measures to avoid heat-related illnesses".

Prolonged exposure to high temperatures can lead to dehydration, heat exhaustion, and heatstroke, which can be fatal if untreated.

Heat also places extra strain on the heart and lungs, increasing the risk of heart attacks and respiratory distress.

Heatwaves can increase the risk of deaths among the elderly and those with underlying medical conditions. It can also affect healthy and young people. Exposure to intense heat can cause headaches, dizziness, cramps, and fainting, particularly for those working outdoors or engaging in strenuous activity.

"Elderly people, kids, and those with chronic conditions like heart disease or diabetes face higher risks, so check on neighbors and family daily," Dr. Meenakshi Jain Principal Director & HOD Internal Medicine, Max Super Speciality Hospital, told HealthandMe.

She urged people to "watch for warning signs like dizziness, rapid heartbeat, nausea, or confusion, and move to a cool area immediately if they appear—seek medical help for severe symptoms. Keep homes cooler by closing curtains during the day and opening windows at night".

How To Stay Safe

• Stay well-hydrated by drinking plenty of water
• Avoid caffeine
• Avoid stepping out during peak afternoon hours
• Wear light, loose, and breathable clothing,
• Use protective gear like caps or umbrellas when outdoors
• Avoid excessive physical activity in the sun.
• Never leave children or elderly individuals in parked vehicles. Include fruits and fluids in your diet to maintain electrolyte balance.
• If you experience dizziness, headache, or fatigue, seek medical attention promptly, as early care can prevent serious complications.